Laurion Capital Management LP Fulcrum Therapeutics, Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.18 - $6.86 $353,221 - $761,981	111,076 Added 330.14%	144,721 $976,000
Q2 2023 Aug 14, 2023	BUY	$2.26 - $3.8 $76,037 - $127,851	33,645 New	33,645 $111,000
Q1 2020 May 14, 2020	SELL	$9.49 - $21.26 $318,408 - $713,315	-33,552 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$4.46 - $18.14 $272,952 - $1.11 Million	-61,200 Reduced 64.59%	33,552 $558,000
Q3 2019 Nov 13, 2019	BUY	$6.64 - $14.89 $629,153 - $1.41 Million	94,752 New	94,752 $629,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $156M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.